LIPG endothelial lipase and breast cancer risk by subtypes
Abstract Experimental data showed that endothelial lipase (LIPG) is a crucial player in breast cancer. However, very limited data exists on the role of LIPG on the risk of breast cancer in humans. We examined the LIPG-breast cancer association within our population-based case–control study from Gali...
Guardado en:
Autores principales: | Manuela Gago-Dominguez, Carmen M. Redondo, Manuel Calaza, Marcos Matabuena, Maria A. Bermudez, Roman Perez-Fernandez, María Torres-Español, Ángel Carracedo, J. Esteban Castelao |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8a818072829441788ab4a112069dbab0 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
FoxA and LIPG endothelial lipase control the uptake of extracellular lipids for breast cancer growth
por: Felipe Slebe, et al.
Publicado: (2016) -
Endothelial lipase mediates efficient lipolysis of triglyceride-rich lipoproteins.
por: Sumeet A Khetarpal, et al.
Publicado: (2021) -
Molecular subtyping of serous ovarian tumors reveals multiple connections to intrinsic breast cancer subtypes.
por: Jenny-Maria Jönsson, et al.
Publicado: (2014) -
Angiotensin II upregulates endothelial lipase expression via the NF-kappa B and MAPK signaling pathways.
por: Xiaoli Zhang, et al.
Publicado: (2014) -
Proteomic maps of breast cancer subtypes
por: Stefka Tyanova, et al.
Publicado: (2016)